F-Prime Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 30
Professionals
  • Investments
  • 434
  • Portfolio
  • 153
  • Exits
  • 131
Exits

F-Prime Capital General Information

Description

Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in information technology, healthcare, life sciences sectors in the United States and Europe..

Contact Information

Website
www.fprimecapital.com
Formerly Known As
Fidelity Biosciences
Year Founded
1969
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Impact Investing
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

F-Prime Capital Investments (434)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Canary Technologies 24-Feb-2022 Early Stage VC 0000 Business/Productivity Software Generating Revenue 000000 0000
000000000 00000000 23-Feb-2022 00000 00000 0000 Electrical Equipment Generating Revenue
00000 16-Feb-2022 00000 00000 0000 Other Healthcare Services Generating Revenue
00000000000 09-Feb-2022 00000 00000 0000 Educational Software Generating Revenue 00000 0000
0000000000 26-Jan-2022 00000 00000 0000 Business/Productivity Software Generating Revenue
000000 0000 25-Jan-2022 00000 00000 00000 Drug Discovery Generating Revenue 0000000 000000 00
000000 10-Jan-2022 00000 00000 00.00 Business/Productivity Software Generating Revenue
000000 15-Dec-2021 00000 00000 0000 Financial Software Generating Revenue
MoEngage 07-Dec-2021 Later Stage VC 0000 Business/Productivity Software Generating Revenue
AviadoBio 02-Dec-2021 Early Stage VC 00000 Drug Discovery Startup 00000 00000 00
You’re viewing 10 of 434 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

F-Prime Capital Exits (131)

Company Name Exit Date Exit Type Exit Size
Optimus Ride 12-Jan-2022 Merger/Acquisition
0000000 000000 06-Jan-2022 000000000000000000
0000 (000000000 00 16-Dec-2021 000000000000000000 00000
00000000000 000000 10-Dec-2021 000 00000
000000000 07-Dec-2021 0000000000
0000000 0000000000 04-Nov-2021 000 00000
00000 000000000000 22-Oct-2021 000 00000
00000000000 18-Oct-2021 000000000000000000 00000
PharmEasy 18-Oct-2021 Secondary Transaction - Private 00000
Threat Stack 04-Oct-2021 Merger/Acquisition 0000
You’re viewing 10 of 131 exits. Get the full list »

F-Prime Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

F-Prime Capital Team (93)

Name Title Deals Funds Boards Office
Stephen Knight MD President & Managing Partner 00 0 00 Cambridge, MA
Stacie Weninger Ph.D President, FBRI 0 0 0 Cambridge, MA
Mary Pendergast Partner & Chief Operating Officer 0 Cambridge, MA
Amber Cai Ph.D Venture Partner Cambridge, MA
Eric Blatte Venture Partner Cambridge, MA
You’re viewing 5 of 93 team members. Get the full list »

F-Prime Capital Co-Investors (710)

Name With Exits Lead Partner Series Industry
Eight Roads 49 0 00 Series chart Industry bar
GV 00 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
Maverick Ventures 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 710 co-investors. Get the full list »